Purpose Overweight or obese breast cancer patients have a worse prognosis compared
with normal-weight patients. This may be attributed to hyperinsulinemia and dysregulation of …

Introduction Several in vitro studies have suggested the effects of adipokines and insulin
resistance on breast cancer cell proliferation and survival. However, little is known about the …

Purpose Adipokines are linked to obesity and insulin sensitivity and have recently been
related to breast cancer risk and prognosis. We investigated the associations of plasma …

The adipocytokines are biologically active polypeptides that are produced either exclusively
or substantially by the adipocytes, and act by endocrine, paracrine, and autocrine …

Adiponectin, an adipocyte-secreted hormone, is closely and inversely associated with
insulin resistance and was recently found to be inversely and independently associated with …

Purpose: Adiponectin is a peptide hormone secreted from the adipose tissue, affecting the
proliferation and insulin sensitivity of various types of cells. Because association of obesity …

Background: Obesity is a major risk factor for breast cancer. We hypothesized that obesity-
induced decreases in total and/or high-molecular-weight (HMW) adiponectin levels may …

Adiponectin is a peptide hormone secreted exclusively by adipocytes, and obesity is an
established risk factor for breast cancer. We have, thus, evaluated the associations of …

Adipokines (leptin, adiponectin, and hepatocyte growth factor (HGF)) secreted from adipose
tissue have come to be recognized for their contribution to the mechanisms by which obesity …

Background: Accumulating data have found that adiponectin is involved in development of
breast cancer (BC). However, these results were inconsistent. Method: A systematic search …